These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35335338)

  • 21. Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
    Magotra A; Sharma A; Gupta AP; Wazir P; Sharma S; Singh PP; Tikoo MK; Vishwakarma RA; Singh G; Nandi U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():200-206. PubMed ID: 28623772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
    Sengottuvelan S; Uppal R; Vuppu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LC-MS/MS method for the determination of clodronate in human plasma.
    Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
    Wang G; Wang H; Lin Z; Hou L; Wang JY; Sun L
    J Ethnopharmacol; 2022 Jan; 282():114560. PubMed ID: 34454053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of an LC-ESI-MS/MS method for the determination of apalutamide, a novel non-steroidal anti-androgen in mice plasma and its application to a pharmacokinetic study in mice.
    Hallur G; Purra BR; Sulochana SP; Saini NK; Daram P; Zainuddin M; Mullangi R
    J Pharm Biomed Anal; 2018 May; 153():260-266. PubMed ID: 29518645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases: Application to pharmacokinetic studies.
    Ekpenyong O; Cooper C; Ma J; Liang D; Olaleye O; Xie H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():35-43. PubMed ID: 30199748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
    Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
    J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a LC-ESI-MS/MS method for the determination of swertiamarin in rat plasma and its application in pharmacokinetics.
    Li HL; Peng XJ; He JC; Feng EF; Xu GL; Rao GX
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1653-8. PubMed ID: 21531636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A validated LC-MS/MS method for the determination of RAF inhibitor LXH254: Application to pharmacokinetic study in rat.
    Li R; Ren M; Lu W; Yuan Y; Li J; Zhong W
    Biomed Chromatogr; 2021 Feb; 35(2):e4968. PubMed ID: 32881002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of an LC-MS/MS method for the determination of SB-505124 in rat plasma: Application to pharmacokinetic study.
    Jiang J; Zhang Y; Zhang Q; Li Y; Gong T; Zhang Z; Ding R; Sun X
    J Pharm Biomed Anal; 2016 Jan; 117():205-9. PubMed ID: 26363490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous Determination of Metformin, Metoprolol and its Metabolites in Rat Plasma by LC-MS-MS: Application to Pharmacokinetic Interaction Study.
    Ma YR; Rao Z; Shi AX; Wang YF; Huang J; Han M; Wang XD; Jin YW; Zhang GQ; Zhou Y; Zhang F; Qin HY; Wu XA
    J Chromatogr Sci; 2016 Jan; 54(1):1-9. PubMed ID: 26187926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LC-MS/MS method for determination of seneciphylline and its metabolite, seneciphylline N-oxide in rat plasma, and its application to a rat pharmacokinetic study.
    Long F; Ji J; Wang X; Wang L; Chen T
    Biomed Chromatogr; 2021 Sep; 35(9):e5145. PubMed ID: 33886121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An LC-MS/MS method for simultaneous determination of trantinterol and its major metabolite in rat plasma and its application to a comparative pharmacokinetic study.
    Wang Y; Qin F; Xiong Z; Fu X; Ma C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():163-8. PubMed ID: 26245359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative determination of euphol in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
    Xie X; Li Y; Gao D; Zhang Y; Ren Y
    Biomed Chromatogr; 2014 Sep; 28(9):1229-34. PubMed ID: 25237707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validated LC-ESI-MS/MS method for the determination of tunicamycin in rat plasma: Application to a pharmacokinetic study.
    Gabani BB; Sulochana SP; Kiran V; Todmal U; Mullangi R
    Biomed Chromatogr; 2019 Nov; 33(11):e4661. PubMed ID: 31325183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of a LC-MS/MS Method for Quantification of Mobocertinib (TAK-788) in Plasma and its Application to Pharmacokinetic Study in Rats.
    Li B; Wang J; Dou X; Zhang X; Xue X; Xu Q; Ran W; Xiong S
    Comb Chem High Throughput Screen; 2021; 24(9):1410-1416. PubMed ID: 33155888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: application to a pharmacokinetic study.
    Chang YW; Chen WC; Lin KT; Chang L; Yao HT; Hsieh HP; Lan SJ; Chen CT; Chao YS; Yeh TK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):162-8. PubMed ID: 17005456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics, bioavailability and metabolism of cligosiban, an antagonist of oxytocin receptor, in rat by liquid chromatography hyphenated with electrospray ionization tandem mass spectrometry.
    Yue X; Lu L; Liu H; Xue H
    J Pharm Biomed Anal; 2019 Feb; 164():725-733. PubMed ID: 30472591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of ginsenoside Rh3 in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
    Yang T; Xu W; Wei X; Zhang Z; Sun Y; Liu H; Yu P; Li W; Yu D
    Biomed Chromatogr; 2022 Feb; 36(2):e5268. PubMed ID: 34676576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioactive indanes: Development and validation of an LC-MS/MS bioanalytical method for the determination of PH46A, a new potential anti-inflammatory agent, in dog and rat plasma and its application to a pharmacokinetic study in dog.
    Scalabrino GA; Zhang T; Frankish N; Sheridan H
    J Pharm Biomed Anal; 2020 Feb; 179():113011. PubMed ID: 31835124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.